רנקסה 1000 מ"ג

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Wirkstoff:

RANOLAZINE 1000 MG

Verfügbar ab:

NEOPHARM LTD

ATC-Code:

C01EB18

Darreichungsform:

TABLETS EXTENDED RELEASE

Verabreichungsweg:

PER OS

Hergestellt von:

CV THERAPEUTICS INC, USA

Therapiegruppe:

RANOLAZINE

Anwendungsgebiete:

Ranexa is indicated for the treatment of chronic angina. Ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).Ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.

Berechtigungsdatum:

2010-10-01